GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like New Study Assesses The Utility Of Masimo PVi Monitoring During Colorectal Surgery February 26, 2017 Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow November 29, 2017 Regeneron Keeps Science at the Center January 16, 2018
